InvestorsHub95d agobearish
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculationNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
106last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com97d agobearish
Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZenecaThe Wall Street Journal97d agobearish
AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks